BW-192C86

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBW-192C86
Drug Alias NameBW-192C86192C86
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin agonistsPlatelet aggregation inhibitors
TargetsProstaglandin
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A